Codexis

Youtube Subscribe

Open: 3.07 Close: 2.93 Change: -0.14

What an AI found about Codexis Stock after reading the whole Internet.

Are looking for the most relevant information about Codexis? Investor spend a lot of time searching for information to make investment decisions in Codexis. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Codexis are: Codexis, agreement, Aldevron, RNA, Inc, enter, Codex, and the most common words in the summary are: codexis, stock, job, inc, best, cdxs, news, . One of the sentences in the summary was: Codexis shares were up 19% at $2.48 a day after it entered into an …

Concept Map

Semantic Network

Stock Summary

Codexis reported an EPS of -$0.17 in its last earnings report, beating expectations of -0.214. Codexiss price range in the past 12 months was $2.19..

Today's Summary

Codexis shares were up 19% at $2.48 a day after it entered into an agreement with Aldevron. Codexis CEO Stephen Dilly named a finalist for the prestigious 2023 Bloom Burton award.

Today's News

Codexis Inc. (CDXS) has entered into an agreement with Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, whereby Aldevrons will acquire a global exclusive license to Codexis Codex HiCap RNA Polymerase. Codexis stock moved upwards by 19.61% since 2021. Aldevron signs agreement to acquire license to Codex HiCap RNA Polymerase. Codexis has 93.55% upside potential, based on the analysts average price target. Codexiss analyst rating consensus is a Moderate Buy. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. Codexis unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation. Codexis, Inc. entered into an exclusive licensing agreement with Aldevron for our Codex® HiCap RNA Polymerase. Codexis CEO Stephen Dilly named a finalist for the prestigious 2023 Bloom Burton award. Codexiss beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated to the rest of the market. Codexis, Inc. (CDXS) has fallen 5.08% Friday in premarket trading. Codexis shares were up 19% at $2.48 a day after it entered into an agreement with Aldevron.

Stock Profile

" Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics. Codexis is developing its proprietary ECO Synthesis™ platform to enable the scaled manufacture of RNAi therapeutics. Codexis Inc. (CDXS) stock price today, quote & news | seeking alpha. Join the Summer Sale! Skip the content Skip to content. Codexis reported an EPS of -$0.17 in its last earnings report, beating expectations of -0.214. Codexis has 69,803,990 shares outstanding. Codexiss price range in the past 12 months was $2.19. Codexis reports second quarter 2023 financial results. Codexis reiterates its 20th financial guidance issued on July 20, 2023. Product revenues are expected to be in the range of $30 million to $35 million. Codexis delivered earnings and revenue surprises of 19.05% and 0.84% for the quarter ended June 2023. Codexis pulled back from biotherapeutics as it cuts staff by 25%. The company, which signed a lease two years ago in San Carlos, will consolidate its staff at its Redwood City headquarters. Codexis, Inc. reports financial results for the second quarter ended June 30, 2023. Codexis to Participate in Jefferies 2023 Healthcare Conference, being held June 7-9, in New York, New York."

Keywords

How much time have you spent trying to decide whether investing in Codexis? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Codexis are: Codexis, agreement, Aldevron, RNA, Inc, enter, Codex, and the most common words in the summary are: codexis, stock, job, inc, best, cdxs, news, . One of the sentences in the summary was: Codexis shares were up 19% at $2.48 a day after it entered into an agreement with Aldevron. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #codexis #stock #job #inc #best #cdxs #news.

Read more →

Youtube Subscribe

---